Research output per year
Research output per year
- 11 results
Search results
-
2021
Mutant myogenin promoter-controlled oncolytic adenovirus selectively kills PAX3-FOXO1-positive rhabdomyosarcoma cells
Yoshida, H., Sato-Dahlman, M., Hajeri, P., Jacobsen, K. L., Koodie, L., Yanagiba, C., Shanley, R. & Yamamoto, M., Feb 2021, In: Translational Oncology. 14, 2, 100997.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
2020
Oncolytic adenoviruses: Strategies for improved targeting and specificity
Hajeri, P. B., Sharma, N. S. & Yamamoto, M., Jun 2020, In: Cancers. 12, 6, p. 1-26 26 p., 1504.Research output: Contribution to journal › Review article › peer-review
Open Access18 Scopus citations -
2018
miR-125a-5p regulation increases phosphorylation of FAK that contributes to imatinib resistance in gastrointestinal stromal tumors
Huang, W. K., Akçakaya, P., Gangaev, A., Lee, L., Zeljic, K., Hajeri, P., Berglund, E., Ghaderi, M., Åhlén, J., Bränström, R., Larsson, C. & Lui, W. O., Oct 1 2018, In: Experimental Cell Research. 371, 1, p. 287-296 10 p.Research output: Contribution to journal › Article › peer-review
Open Access27 Scopus citations -
2017
CD133-targeted oncolytic adenovirus demonstrates anti-tumor effect in colorectal cancer
Sato-Dahlman, M., Miura, Y., Huang, J. L., Hajeri, P., Jacobsen, K., Davydova, J. & Yamamoto, M., 2017, In: Oncotarget. 8, 44, p. 76044-76056 13 p.Research output: Contribution to journal › Article › peer-review
Open Access35 Scopus citations -
Loss of miR-514a-3p regulation of PEG3 activates the NF-kappa B pathway in human testicular germ cell tumors
Özata, D. M., Li, X., Lee, L., Liu, J., Warsito, D., Hajeri, P., Hultman, I., Fotouhi, O., Marklund, S., Ährlund-Richter, L., Juhlin, C. C., Larsson, C. & Lui, W. O., 2017, In: Cell Death and Disease. 8, 5, e2759.Research output: Contribution to journal › Article › peer-review
Open Access47 Scopus citations -
2014
Sequential expression of miR-182 and miR-503 cooperatively targets FBXW7, contributing to the malignant transformation of colon adenoma to adenocarcinoma
Li, L., Sarver, A. L., Khatri, R., Hajeri, P. B., Kamenev, I., French, A. J., Thibodeau, S. N., Steer, C. J. & Subramanian, S., Dec 1 2014, In: Journal of Pathology. 234, 4, p. 488-501 14 p.Research output: Contribution to journal › Article › peer-review
Open Access53 Scopus citations -
2012
Rna Interference: From basics to Therapeutics
Kumar Singh, S. & Hajeri, P. B., Mar 16 2012, Molecular and Cellular Therapeutics. John Wiley and Sons, p. 140-167 28 p.Research output: Chapter in Book/Report/Conference proceeding › Chapter
1 Scopus citations -
Rna Interference: From basics to Therapeutics
Kumar Singh, S. & Hajeri, P. B., Mar 16 2012, Molecular and Cellular Therapeutics. John Wiley and Sons, p. 140-167 28 p.Research output: Chapter in Book/Report/Conference proceeding › Chapter
1 Scopus citations -
2009
MicroRNA tales in fly development
Bhadra, U., Singh, S. K., Pushpavalli, S. N. C. V. L., Hajeri, P. B. & Pal-Bhadra, M., Apr 27 2009, Regulation of Gene Expression by Small RNAs. CRC Press, p. 123-147 25 p.Research output: Chapter in Book/Report/Conference proceeding › Chapter
-
siRNAs: their potential as therapeutic agents - Part I. Designing of siRNAs
Hajeri, P. B. & Singh, S. K., Sep 2009, In: Drug Discovery Today. 14, 17-18, p. 851-858 8 p.Research output: Contribution to journal › Review article › peer-review
34 Scopus citations -
siRNAs: their potential as therapeutic agents - Part II. Methods of delivery
Singh, S. K. & Hajeri, P. B., Sep 2009, In: Drug Discovery Today. 14, 17-18, p. 859-865 7 p.Research output: Contribution to journal › Review article › peer-review
30 Scopus citations